
|Articles|August 2, 2002
- Pharmaceutical Technology-08-02-2002
- Volume 26
- Issue 8
Risk Management Shapes FDA Policies and Practices
Author(s)Jill Wechsler
In response to increasing concern about drug safety, FDA has implemented several administrative and policy changes, inclduing the new Office of Pharmacoepidemiology and Statistical Science and a renewed focus on risk assessment.
Advertisement
Articles in this issue
almost 24 years ago
Packaging Advances ShowcasedAdvertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
2
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
3
The Next Generation of Medicine: Personalized, Preventive, and Powered by Technology
4
The FDA Moves to Modernize Drug Manufacturing Registration
5




